Last reviewed · How we verify

NCT05739396

Core Stabalization and Rebound Therapy and CP

Status unknown NA Last updated 1 March 2023
What this trial tests

NA trial testing core stabilization in Whole Body Vibration in 26 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
1 June 2023
11 July 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment26
Start date1 February 2023
Primary completion1 June 2023
Estimated completion11 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 5 to 8, any sex, with Whole Body Vibration or Rebound Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study aims to compare the effect of core stabalization and rebound therapy on balance in children with hemiplegic cerebral palsy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of core stabilization versus rebound therapy on balance in children with cerebral palsy.
    Al-Nemr A, Kora AN. · · 2024 · cited 1× · PMID 38177509 · DOI 10.1007/s13760-023-02430-8

Verify or expand the search:

Other recruiting trials for Whole Body Vibration

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05739396.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing